These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24992319)

  • 1. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability.
    Godinho BM; Ogier JR; Quinlan A; Darcy R; Griffin BT; Cryan JF; O'Driscoll CM
    Int J Pharm; 2014 Oct; 473(1-2):105-12. PubMed ID: 24992319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery.
    O'Mahony AM; Ogier J; Desgranges S; Cryan JF; Darcy R; O'Driscoll CM
    Org Biomol Chem; 2012 Jul; 10(25):4954-60. PubMed ID: 22614240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
    Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
    Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
    Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
    J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
    Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
    Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's disease.
    Godinho BM; Ogier JR; Darcy R; O'Driscoll CM; Cryan JF
    Mol Pharm; 2013 Feb; 10(2):640-9. PubMed ID: 23116281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.
    Lo JH; Kwon EJ; Zhang AQ; Singhal P; Bhatia SN
    Bioconjug Chem; 2016 Oct; 27(10):2323-2331. PubMed ID: 27583545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.
    O'Mahony AM; Desgranges S; Ogier J; Quinlan A; Devocelle M; Darcy R; Cryan JF; O'Driscoll CM
    Pharm Res; 2013 Apr; 30(4):1086-98. PubMed ID: 23192687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
    Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
    J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis.
    Gooding M; Malhotra M; McCarthy DJ; Godinho BM; Cryan JF; Darcy R; O'Driscoll CM
    Eur J Pharm Sci; 2015 Apr; 71():80-92. PubMed ID: 25703259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes.
    Buyens K; Demeester J; De Smedt SS; Sanders NN
    Langmuir; 2009 May; 25(9):4886-91. PubMed ID: 19341292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
    Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
    J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated iminodiacetic acid zinc complex stabilizes cationic RNA-bearing nanoparticles.
    Levy DE; Ding Z; Hu C; Zalipsky S
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5499-501. PubMed ID: 20696578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic Mucic Acid Polymer-Based siRNA Delivery Systems.
    Pan DW; Davis ME
    Bioconjug Chem; 2015 Aug; 26(8):1791-803. PubMed ID: 26154102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery.
    O'Mahony AM; Ogier J; Darcy R; Cryan JF; O'Driscoll CM
    PLoS One; 2013; 8(6):e66413. PubMed ID: 23805220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.